Nektar Therapeutics
NKTR
NKTR
377 hedge funds and large institutions have $7.83B invested in Nektar Therapeutics in 2018 Q2 according to their latest regulatory filings, with 98 funds opening new positions, 128 increasing their positions, 128 reducing their positions, and 74 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
377
Holders Change
+19
Holders Change %
+5.31%
% of All Funds
8.64%
Holding in Top 10
6
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-66.67%
% of All Funds
0.14%
New
98
Increased
128
Reduced
128
Closed
74
Calls
$231M
Puts
$193M
Net Calls
+$37.8M
Net Calls Change
-$149M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$163M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$78.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.4M |
| 4 |
JPMorgan Chase & Co
New York
|
+$42.6M |
| 5 |
O
OppenheimerFunds
New York
|
+$41.3M |
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$130M |
| 2 |
DFO
Duquesne Family Office
New York
|
-$127M |
| 3 |
BlackRock
New York
|
-$88.5M |
| 4 |
PC
PointState Capital
New York
|
-$66.2M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$60.3M |
